Sunshine Biopharma, Inc. (SBFM) NASDAQ
2.66
+0.06(+2.31%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.66
+0.06(+2.31%)
Currency In USD
| Market Cap | 5.11M |
| Enterprise Value | -3.2M |
| P/E Ratio | -0.22 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0.04 |
| Price/Book Ratio | 0.06 |
| Enterprise/Revenue | -0.14 |
| Enterprise/EBITDA | 0.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.17 |
| Operating Margin | -0.13 |
| Return On Assets | -0.22 |
| Return On Equity | -0.26 |
| Revenue | 36.31M |
| Revenue/Share | 72.35 |
| Gross Profit | 11.92M |
| EBITDA | -4.15M |
| Net Income | -5.98M |
| Diluted EPS | -14.4 |
| Total Cash | 6.91M |
| Total Cash/Share | 14.09 |
| Total Debt | 744,840 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 4.22 |
| Book Value Per Share | 43.86 |
| 52-Week Change | -82.84 |
| 52-Week High | 24.3 |
| 52-Week Low | 2.11 |
| Moving Average 50 Days | 8.52 |
| Moving Average 200 Days | 12.76 |
| Average Volume | 1.53M |
| Shares Outstanding | 500,595 |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 01, 2026 |